Practice resources

SIR's comment letter archive

Between January 2019 to the current date, the SIR economics team sent several carrier-advocacy letters on behalf of our membership. These letters were written to properly advocate for appropriate reimbursement of specific IR procedures such as:

Submit claims denials here

 

 

Prior to 2018 comment letters

Date

Carrier/payor

Coverage issue

11/30/2017

United Healthcare Medical Technology Assessment Committee

Draft Implantable Beta-Emitting Microspheres Treatment of Malignant Tumor (Version 2) Policy document

10/24/2017

First Coast Service Options

Endovenous mechanochemical ablation (MOCA) ClariVein

8/2/2017

MAC – National Government Services, Inc (NGS) – LCD

Varicose Veins of the Lower Extremity (DL33575)

7/6/2017

First Coast Service Options Medical Policy

PROPOSED/DRAFT Local Coverage Determination (LCD): Lower Extremity Revascularization (DL37404)

3/9/2017

MAC - Novitas Solutions, Inc (LCD)

Veins of the Lower Extremities (DL34924)

2/7/2017

Noridian, LLC

Request to Retire Article (A54072) Restricting Medicare Coverage of Treatment with Yttrium-90 Microspheres

8/31/2016

EmblemHealth, Inc.

Endovenous mechanochemical ablation (MOCA) ClariVein

8/31/2016

Blue Cross Blue Shield (Illinois)

Endovenous mechanochemical ablation (MOCA) ClariVein

8/3/2016

Center for Evidence and Practice Improvement Agency for HealthCare Research and Quality

Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease (LECVD)

5/6/2016

Helpline Advocate/Health Care Bureau Office of the Attorney General

Y-90 treatment of women with metastatic breast cancer to the liver

4/19/2016

United Healthcare

Pelvic Congestion Syndrome (PCS)

11/30/2015

National Medical Director United Health Care

Request for in-person meeting at UHC offices to review latest literature on Uterine Artery Embolization for relief of symptomatic fibroids

8/7/2015

Highmark Inc. Medical Management & Policy

Our phone call of July 17, 2015 regarding Uterine Artery Embolization

5/11/2015

Blue Cross Blue Shield (Highmark)

Uterine Artery Embolization(UAE) for women with symptomatic fibroids

2/13/2015

Centers for Medicare & Medicaid Services (CMS)

Coated Percutaneous Transluminal Angioplasty (PTA) Balloon

12/10/2014

Oregon Health Evidence Review Commission

Public comment: IVC filter evidence review

8/11/2014

Division of Dockets Management U.S. Food and Drug Administration

FDA-2014-N-0736: Comments on Laparoscopic Power Morcellation Devices

6/2/2014

WellPoint Inc. Office of Medical Policy & Technology Assessment

Feedback on Percutaneous Vertebroplasty and Sacroplasty (policy # 6.01.25)

5/13/2013

Office of Medical Policy & Technology Assessment Wellpoint, Inc

Draft SURG.00122 (venous angioplasty with or without stent placement)

4/8/2013

Centers for Medicare & Medicaid Services (CMS)

Part II—Regulatory Provisions to Promote Program Efficiency, Transparency, and Burden Reduction: Proposed Rule CMS–3267–P

2/11/2013

Novitas Solutions - Office of the Medical Director

Reported coding denials for routine Interventional Radiology procedures in the transition from Trailblazer to Novitas

1/2/2013

WellPoint Inc. Office of Medical Policy & Technology Assessment

Society of Interventional Radiology comments on carotid atherosclerosis and carotid artery stenting

12/13/2012

Washington State Health Care Authority Health Technology Assessment Program

Society of Interventional Radiology comments on carotid atherosclerosis and carotid artery stenting: Questions for Consideration

9/14/2012

Humana

Percutaneous kyphoplasty (CPT codes 22523, 22524, 22525) procedures

5/30/2012

Oregon Health Evidence Review Commission

VERTEBROPLASTY, KYPHOPLASTY, SACROPLASTY

5/15/2012

Noridian CGS RTG 795

Percutaneous kyphoplasty (CPT codes 22523, 22524, 22525) in the nonfacility setting

4/3/2012

Office of Medical Policy & Technology Assessment Wellpoint, Inc

Occlusion of Uterine Arteries Using Transcatheter Embolization (policy #4.01.11)

3/14/2012

Noridian Administrative Services, LLC

Concern over Claims Processing for Vertebroplasty and Kyphoplasty

2/3/2012

California Technology Assessment Forum (CTAF)

Atherosclerotic Renal Artery Stenosis Indications for Renal Artery Stent Placement

1/6/2012

Wisconsin Physicians Service Medicare

Venous Angioplasty with or without Stent Placement for the Treatment of Chronic Cerebrospinal Venous Insufficiency (CV-041)

12/19/2011

Medicare Evidence Development & Coverage Advisory Committee Centers for Medicare & Medicaid Services

Society of Interventional Radiology comments on carotid atherosclerosis and treatment: January 25, 2012 meeting

9/27/2011

Aetna

Stent Policy

6/20/2011

MAC - Noridian Administrative Services, LLC (NAS) - LCD

DL32032: Vertebroplasty, Vertebral Augmentation; Percutaneous

2/25/2011

Office of Medical Policy & Technology Assessment Wellpoint, Inc

Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial
Embolization (TAE) for Malignant Lesions Outside the Liver: RAD.00059

10/22/2010

Health Technology Assessment Program Washington State Health Care Authority

Draft Assessment- Vertebroplasty, Kyphoplasty, Sacroplasty

8/23/2010

MAC - Cahaba Government Benefit Administrators, LLC (CGBA) - LCD

DL231295- Radiology, Ultrasound Guidance for Vascular Access Requiring
Ultrasound Evaluation of Potential Access Sites

5/5/2010

Office of Medical Policy & Technology Assessment WellPoint, Inc.

Wellpoint Draft Medical Policy SURG.00067: Percutaneous Spinal Procedures (Vertebroplasty, Kyphoplasty, and Sacroplasty)